South Africa received its second batch of COVID-19 vaccines early Saturday morning aboard a South African Airways flight. The 80,000 doses of the Johnson and Johnson vaccine will bolster the country’s vaccination drive.
South Africa had earlier planned to use the AstraZeneca vaccine and had purchased and received 1 million doses.
But then a small, preliminary study showed that the AstraZeneca vaccine provided only 22 percent protection against mild to moderate disease caused by the COVID-19 variant now dominant in South Africa.
The second batch of vaccines is been reserved for frontline health care workers.
The single-shot Johnson & Johnson vaccine has been shown to be 82 percent effective in preventing severe illness from the coronavirus variant first discovered in South Africa.